{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:56:41Z","timestamp":1771549001087,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113172","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:43:23Z","timestamp":1726728203000},"page":"113172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PB","title":["Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression"],"prefix":"10.1016","volume":"142","author":[{"given":"Zhang","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113172_b0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.7150\/jca.81899","article-title":"Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.113172_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00940-z","article-title":"SBRT combined with PD-1\/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges","volume":"13","author":"Chen","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2024.113172_b0015","first-page":"41","article-title":"Advances in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Targeted Therapy","volume":"2","author":"Giustini","year":"2020","journal-title":"Clin. Chest Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113172_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2021.12.005","article-title":"EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion","volume":"185","author":"Marzio","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.113172_b0025","article-title":"Tumor-infiltrating B cells:their role and application in antitumor immunity in lung cancer","volume":"016(001):P.6-18","author":"Wang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.113172_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells11243958","article-title":"Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway","volume":"11","author":"Wang","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2024.113172_b0035","article-title":"Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives","volume":"157","author":"Imyanitov","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.intimp.2024.113172_b0040","first-page":"3","article-title":"Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment","volume":"3","author":"Kenji","year":"2023","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.113172_b0045","article-title":"Adding PD-1\/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials","volume":"12","author":"Tiseo","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.intimp.2024.113172_b0050","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1016\/S1569-9056(19)31428-9","article-title":"Palmitoylethanolamide\/polydatin as add-on therapy in pain resistant patients with interstitial cystitis\/bladder painful syndrome","volume":"18","author":"Gubbiotti","year":"2019","journal-title":"Eur. Urol. Suppl."},{"issue":"1","key":"10.1016\/j.intimp.2024.113172_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02283-2","article-title":"Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury","volume":"18","author":"Gao","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2024.113172_b0060","series-title":"Liao S","first-page":"471","author":"Wang","year":"2019"},{"key":"10.1016\/j.intimp.2024.113172_b0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biopha.2018.09.051","article-title":"Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-\u03baB pathway","volume":"108","author":"Zou","year":"2018","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie."},{"key":"10.1016\/j.intimp.2024.113172_b0070","article-title":"Polydatin protects against articular cartilage degeneration by regulating autophagy mediated by the AMPK\/mTOR signaling pathway","volume":"18739","author":"Ye","year":"2024","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.intimp.2024.113172_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101865","article-title":"Polydatin inhibits IL-1\u03b2-mediated chondrocyte inflammation and ameliorates cartilage degradation: Involvement of the NF-\u03baB and Wnt\/\u03b2-catenin pathways","volume":"78","author":"Hu","year":"2022","journal-title":"Tissue Cell"},{"issue":"2","key":"10.1016\/j.intimp.2024.113172_b0080","article-title":"Hepatoprotective effects of polydatin-loaded chitosan nanoparticles in diabetic rats: modulation of glucose metabolism, oxidative stress, and inflammation biomarkers","volume":"86","author":"El-Hameed","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2024.113172_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101865","article-title":"Polydatin inhibits IL-1\u03b2-mediated chondrocyte inflammation and ameliorates cartilage degradation: Involvement of the NF-\u03baB and Wnt\/\u03b2-catenin pathways","author":"Hu","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.intimp.2024.113172_b0090","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/suab130.006","article-title":"51Palmitoylethanolamide associated to polydatin reduces inflammation in human endothelial vascular cells exposed to doxorubicin and trastuzumab through PPAR-a and NLRP3-related pathways","author":"Quagliariello","year":"2021","journal-title":"European Heart Journal Supplements"},{"key":"10.1016\/j.intimp.2024.113172_b0095","first-page":"54","article-title":"ETV5 transcriptionally activates TGF\u03b21 and promotes cancer cell invasion and migration of NSCLC","volume":"5","author":"Dan","year":"2023","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.intimp.2024.113172_b0100","article-title":"Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study","author":"Klarenbeek","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2024.113172_b0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41416-021-01572-x","article-title":"A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications","volume":"126","author":"Patel","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2024.113172_b0110","article-title":"A genome-wide pooled shRNA screen identifies PPP2R2A as a predictive biomarker for the response to ATR and CHK1 inhibitors","volume":"80(16):canres.0057.2020","author":"Qiu","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.113172_b0115","article-title":"The inhibitive effect of polydatin on the proliferation and invasion in lung cancer A549 cells and its mechanism. Tianjin Medical","author":"Bei","year":"2019","journal-title":"Journal"},{"key":"10.1016\/j.intimp.2024.113172_b0120","article-title":"Polydatin suppresses the development of lung inflammation and fibrosis by inhibiting activation of the NACHT domain-, leucine-rich repeat-, and pyd-containing protein 3 inflammasome and the nuclear factor-\u03baB pathway after Mycoplasma pneumoniae infection","volume":"6","author":"Tang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2024.113172_b0125","doi-asserted-by":"crossref","DOI":"10.2131\/jts.48.299","article-title":"The mechanism of monobutyl phthalate-induced ferroptosis via TNF\/IL6\/STAT3 signal pathway in TM-3 cells","author":"Guo","year":"2023","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.intimp.2024.113172_b0130","article-title":"Astaxanthin alleviates lipopolysaccharide-induced acute lung injury by suppressing ferroptosis","author":"Xue","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2024.113172_b0135","series-title":"Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer","author":"Bartolacci","year":"2021"},{"key":"10.1016\/j.intimp.2024.113172_b0140","first-page":"83","article-title":"EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma","volume":"23","author":"Lv","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2024.113172_b0145","article-title":"ZnT8 Exerts Anti-apoptosis of Kidney Tubular Epithelial Cell in Diabetic Kidney Disease Through TNFAIP3-NF-\u03baB Signal Pathways","author":"Yinmao","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.intimp.2024.113172_b0150","doi-asserted-by":"crossref","unstructured":"Eunmi, Ouzounova, Maria, Piranlioglu, Raziye, Ma MT, et al. The pleiotropic effects of TNF alpha in breast cancer subtypes is regulated by TNFAIP3\/A20 (vol 38, pg 469, 2018). Oncogene. 2019(38-28).","DOI":"10.1038\/s41388-018-0472-0"},{"key":"10.1016\/j.intimp.2024.113172_b0155","doi-asserted-by":"crossref","unstructured":"Guo N. Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma. 2020.","DOI":"10.21203\/rs.3.rs-24079\/v1"},{"issue":"1","key":"10.1016\/j.intimp.2024.113172_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.clcc.2020.12.003","article-title":"MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway","volume":"20","author":"Chuang","year":"2021","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.intimp.2024.113172_b0165","article-title":"617 AMP-IBP5 improves diabetic wound healing via activation of EGFR\/STAT\/MAPK pathways","volume":"141(5):S107-","author":"Yue","year":"2021","journal-title":"J, Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113172_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2020.10.006","article-title":"Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC","volume":"16","author":"Le","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.intimp.2024.113172_b0175","article-title":"Clinical and molecular characteristics of the patients in the liquid biopsy study in mEGFR-NSCLC in a Spanish population (OPH-1)","volume":"38(15_suppl):e21515-e","author":"Franco","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.113172_b0180","first-page":"77","article-title":"Inhibition of NET formation by polydatin protects against collagen-induced arthritis","author":"Yang","year":"2019","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924016941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924016941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T05:58:19Z","timestamp":1734069499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924016941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"alternative-id":["S1567576924016941"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113172","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113172"}}